As Seen In

As Seen In

Streetwise Report Interviews BioWatch News Founder Alan Leong

To read the full report, click here.

Biotechnology can be daunting to comprehend, but understanding is critical
to successful investment. BioWatch News Founder Alan Leong has a nose
for growth names, and his goal is to make their technology platforms clear to
investors who might not be able to make sense of peer-reviewed scientific
literature but want the big upside that science promises. In this interview with
The Life Sciences Report, Leong brings seven micro-cap names with massive
potential to investors’ attention.

The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.